About Carmell Corp. 
Carmell Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 3 Schemes (0.59%)
Foreign Institutions
Held by 6 Foreign Institutions (0.85%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
Pharmaceuticals & Biotechnology
USD 1 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.18
145.64%
-0.13






